Ákos Nádasdi

Ákos Nádasdi

Auto-generated profile, based on publicly available information

Ákos Nádasdi

Semmelweis Egyetem, Általános Orvostudományi Kar, Transzlációs Medicina Intézet Budapest, Tűzoltó u. 37–47., 1094 Magyarország

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KRKlara Rosta
Klara Rosta
ZAZahra Al-Aissa
Zahra Al-Aissa
OHOrsolya Hadarits
Orsolya Hadarits
JHJürgen Harreiter
Jürgen Harreiter
ÁNÁkos Nádasdi
Ákos Nádasdi
GFGabor Firneisz
Gabor Firneisz
Genetic variation in human maternal DNA contributes to the susceptibility for development of gestational diabetes mellitus (GDM). We assessed 77 maternal single nucleotide gene polymorphisms (SNPs) for associations with GDM or plasma glucose levels at OGTT in pregnancy. 960 pregnant women (after dropouts 820: case/control: m99’WHO: 303/517, IADPSG: 287/533) were enrolled in two countries into this case-control study. After genomic DNA isolation the 820 samples were collected in a GDM biobank and assessed using KASP (LGC Genomics) genotyping assay. Logistic regression risk models were used to calculate ORs according to IADPSG/m’99WHO criteria based on standard OGTT values. The most important risk alleles associated with GDM were rs10830963/G of MTNR1B (OR = 1.84/1.64 [IADPSG/m’99WHO], p = 0.0007/0.006), rs7754840/C (OR = 1.51/NS, p = 0.016) of CDKAL1 and rs1799884/T (OR = 1.4/1.56, p = 0.04/0.006) of GCK. The rs13266634/T (SLC30A8, OR = 0.74/0.71, p = 0.05/0.02) and rs7578326/G (LOC646736/IRS1, OR = 0.62/0.60, p = 0.001/0.006) variants were associated with lower risk to develop GDM. Carrying a minor allele of rs10830963 (MTNR1B); rs7903146 (TCF7L2); rs1799884 (GCK) SNPs were associated with increased plasma glucose levels at routine OGTT. We confirmed the robust association of MTNR1B rs10830963/G variant with GDM binary and glycemic traits in this Caucasian case-control study. As novel associations we report the minor, G allele of the rs7578326 SNP in the LOC646736/IRS1 region as a significant and the rs13266634/T SNP (SLC30A8) as a suggestive protective variant against GDM development. Genetic susceptibility appears to be more preponderant in individuals who meet both the modified 99’WHO and the IADPSG GDM diagnostic criteria.

23 February 2022 in Biomarkers in Medicine
Verified
Journal Article
Open access
ÁNÁkos Nádasdi
Ákos Nádasdi
GSGyörgy Sinkovits
György Sinkovits
IBIlona Bobek
Ilona Bobek
Botond LakatosBotond Lakatos
Botond Lakatos
ZFZsolt Förhécz
Zsolt Förhécz
GFGabor Firneisz
Gabor Firneisz
Aim: To investigate the serum circulating DPP4 activity in patients with COVID-19 disease. Materials & methods: Serum samples from 102 hospitalized COVID-19 patients and 43 post-COVID-19 plasma don...

21 March 2023 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
ÁNÁkos Nádasdi
Ákos Nádasdi
VGViktor Gál
Viktor Gál
TMTamás Masszi
Tamás Masszi
ASAnikó Somogyi
Anikó Somogyi
GFGabor Firneisz
Gabor Firneisz
Background: Recent reports suggested a different predictive value for TyG index compared to HOMA-IR in coronary artery calcification (CAC) and other atherosclerotic outcomes, despite that both indices are proposed as surrogate markers of insulin resistance. We hypothesized a key role for liver pathology as an explanation and therefore assessed the relationship among the two indices and the intrahepatic lipid content stratified byPNPLA3rs738409 genotypes as a known non-alcoholic fatty liver disease (NAFLD) genetic risk.Methods: Thirty-nine women from a prior GDM-genetic study were recalled withPNPLA3rs738409CCandGGgenotypes for metabolic phenotyping and to assess hepatic triglyceride content (HTGC). 75 g OGTT was performed, fasting lipid, glucose, insulin levels and calculated insulin resistance indices (TyG and HOMA2-IR) were used. HTGC was measured by MR based methods. Mann–Whitney-U, χ2and for the correlation analysis Spearman rank order tests were applied.Results: ThePNPLA3rs738409 genotype had a significant effect on the direct correlation between the HOMA2-IR and TyG index: the correlation (R = 0.52, p = 0.0054) found in theCCgroup was completely abolished in those with theGG(NAFLD) risk genotype. In addition, the HOMA2-IR correlated with HTGC in the entire study population (R = 0.69, p < 0.0001) and also separately in both genotypes (CCR = 0.62, p = 0.0006,GG: R = 0.74, p = 0.0058). In contrast, the correlation between TyG index and HTGC was only significant in rs738409CCgenotype group (R = 0.42, p = 0.0284) but not inGGgroup. A similar pattern was observed in the correlation between TG and HTGC (CC: R = 0.41, p = 0.0335), when the components of the TyG index were separately assessed.Conclusions: PNPLA3rs738409 risk genotype completely decoupled the direct correlation between two surrogate markers of insulin resistance: TyG and HOMA2-IR confirming our hypothesis. The liver lipid content increased in parallel with the HOMA2-IR independent of genotype, in contrast to the TyG index where the risk genotype abolished the correlation. This phenomenon seems to be related to the nature of hepatic fat accumulation and to the different concepts establishing the two insulin resistance markers.

27 July 2022 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
ÁNÁkos Nádasdi
Ákos Nádasdi
VGViktor Gál
Viktor Gál
TMTamás Masszi
Tamás Masszi
APAttila Patócs
Attila Patócs
PIPeter Igaz
Peter Igaz
GFGabor Firneisz
Gabor Firneisz
Background: TCF7L2 rs7903146 and PNPLA3 rs738409 gene variants confer the strongest risk for type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD), respectively. Pancreatic triacylglycerol content (PTGC) was reported to have a role in T2DM development. We aimed to assess the correlation between PTGC and hepatic triacylglycerol content (HTGC) stratified by PNPLA3 rs738409 genotype and subsequently interactions between PTGC and gene variants associated with β-cell dysfunction (TCF7L2, WFS1) and visceral adiposity (11ΒHSD1) on β-cell function were also tested. Methods: PTGC and HTGC were assessed using MR in a post-hoc analysis of a genotype-based (PNPLA3 rs738409) recall study of 39 (lipid- and glucose lowering) drug-naïve women. Oral glucose tolerance test, HbA1c, insulin indices, anthropometric data were evaluated. The effect of minor allele carrying of TCF7L2 (rs7903146); WFS1 (rs1801214) and 11ΒHSD1 (rs4844880) variants in combination with PTGC was studied on surrogate markers of β-cell function. We used Spearman’s rank-order, Mann-Whitney-U tests, and linear regression models. Results: PTGC and HTGC values were correlated after stratification by the rs738409 variant (only in CC genotype group R = 0.67, p = 10− 4). PTGC and HbA1c values correlated in the entire study population (R = 0.58, p = 10− 4). Insulin resistance, sensitivity and disposition indices were correlated with PTGC (HOMA2-IR: R = 0.42, p = 0.008; TyG: R = 0.38, p = 0.018; Matsuda: R= − 0.48, p = 0.002; DIbasal: R=−0.33, p = 0.039; ISSI-2: R=−0.35, p = 0.028). Surrogate markers of β-cell function (HOMA2-B, AUCinsulin/AUCglucose) correlated significantly with PTGC in subjects with the following genotypes rs7903146: CC R = 0.51, p = 0.022; rs18001214: CT + CC R = 0.55, p = 0.013; rs4844880: TA + AA R = 0.56, p = 0.016. The strongest interactions were found between PTGC and TCF7L2 rs7903146 effect on HOMA2-B (p = 0.001) and AUCinsulin/AUCglucose (p = 0.013). Conclusions: The PNPLA3 rs738409 genotype has a major effect on the correlation between PTGC and HTGC. Furthermore we first report the combined effect of PTGC and individual risk gene variants of TCF7L2, WFS1 and 11ΒHSD1 on β-cell dysfunction. The correlation between pancreatic lipid accumulation and HbA1c also indicates an important role for the latter pathology.

25 September 2025 in Research Square
Verified
Preprint
Open access
PDF file
GFGabor Firneisz
Gabor Firneisz
BNBotond A. Nemes
Botond A. Nemes
LNLászló Németh
László Németh
ÁNÁkos Nádasdi
Ákos Nádasdi
Zoltán BenyóZoltán Benyó
Zoltán Benyó
Importance: Cesarean delivery (CD) is associated with higher risk of obesity development from childhood and with type 2 diabetes mellitus (T2DM) later in life. Higher neonatal cord C-peptide (CP) levels were reported to be associated with increased risk of offspring metabolic disorders in childhood as well. Objective: To assess the association between mode of delivery as the primary exposure and 27 additional maternal/neonatal clinical factors and the risk of neonatal hyperinsulinemia. Design: Retrospective data analysis. Setting: Multinational, multi-ancestry observational population-based Hyperglycemia Advanced Pregnancy Outcome (HAPO) cohort study gene-environment interaction (GEI) substudy. Participants: A total of 4967 mother-neonate pairs from 4 major ancestry groups (Afro-Caribbean, European, Hispanic, Thai) were assessed. Exposure: Data on mode of delivery and 27 additional (18 maternal + 9 neonatal) variables were utilized from the NIH dbGaP database (accession phs000096.v4.p1). Main outcome and measures: The primary outcome was neonatal hyperinsulinemia herein defined as cord serum CP level of ancestry specific > 90th percentile. χ2-test was used to assess the difference between CD and vaginal delivery groups and standardized multivariate logistic regression with Akaike information criterion-based model selection and interaction analyses were used to model the primary outcome. Missing data were addressed using Bayesian joint modeling approach. Results: Out of the total 4967 pregnancies assessed CD was performed in 1154 mothers (23.2%). Cord blood hyperinsulinemia occurred in 447 cases of which 178 in the CD (15.4%) and 269 in vaginal delivery (7.1%) group (OR crude, 2.4; 95% CI, 1.96 to 2.94). We identified novel factors individually associated with neonatal hyperinsulinemia: CD (OR in firstborns: 4.25; 95% CI, 2.66-6.78, OR in non-firstborns: 4.25; 95% CI, 2.59-6.99) and non-firstborn vaginal delivery (OR, 1.95; 95% CI, 1.34-2.88) when compared to vaginally delivered firstborns. Sensitivity analyses confirmed the stability of these results and subgroup analyses revealed the consistency of the two novel associations across different ancestries. Conclusion: To our best knowledge we first report that neonatal hyperinsulinemia risk is more than quadrupled in neonates born via cesarean delivery independently of birth order when compared to vaginally delivered firstborns. Non-firstborns are also at increased risk.

23 November 2025 in Orvosi Hetilap
Verified
Journal Article
Open access
ÁNÁkos Nádasdi
Ákos Nádasdi
GFGabor Firneisz
Gabor Firneisz
A nem alkoholos zsírmájbetegség (NAFLD) – vagy újabb terminológia alapján metabolikus funkciózavarhoz társuló steatoticus májbetegség (MASLD) – napjaink népbetegsége, amelynek kialakulásában és a spektrumbetegség súlyosabb kórállapotainak megjelenésében (steatoticus májgyulladás, májfibrosis, májcirrhosis és májrák) kiemelkedik a PNPLA3, egy egypontos, aminosavcserével (C>G) járó génvariáns szerepe, amelyet az elmúlt több mint 20 évben kiterjedten vizsgáltak. Mind a klinikai, mind pedig a génterméknek a kórállapot kialakulásában betöltött szerepéről szóló ismeretanyag napról napra bővül, ezáltal egyre jobban megérthetjük a PNPLA3 génvariánsoknak és kódolt fehérjeváltozataiknak az élettani és kóros funkciókban betöltött szerepét. A PNPLA3 -genotipizálás egyelőre még nem része sem a rutindiagnosztikának, sem a terápiás döntéshozatalnak, a rendelkezésre álló kutatási eredmények és a hatásnagyság alapján azonban elképzelhető, hogy prognosztikai és terápiás stratégiákban történő felhasználására sor kerülhet a jövőben, elsősorban a személyre szabott medicina keretein belül. A közlemény célja a jelenleg rendelkezésre álló publikált eredmények strukturált formában történő összefoglalása, amely egyaránt érinti a funkcionalitást, a működést, a klinikai konzekvenciákat, a diagnosztikus/progresszióbecslő és terápiás lehetőségeket. Orv Hetil. 2025; 166(47): 1843–1856.